全文获取类型
收费全文 | 870篇 |
免费 | 45篇 |
学科分类
工业技术 | 915篇 |
出版年
2023年 | 9篇 |
2022年 | 3篇 |
2021年 | 32篇 |
2020年 | 17篇 |
2019年 | 15篇 |
2018年 | 24篇 |
2017年 | 19篇 |
2016年 | 23篇 |
2015年 | 31篇 |
2014年 | 41篇 |
2013年 | 56篇 |
2012年 | 34篇 |
2011年 | 39篇 |
2010年 | 33篇 |
2009年 | 34篇 |
2008年 | 50篇 |
2007年 | 33篇 |
2006年 | 36篇 |
2005年 | 31篇 |
2004年 | 28篇 |
2003年 | 25篇 |
2002年 | 23篇 |
2001年 | 14篇 |
2000年 | 17篇 |
1999年 | 11篇 |
1998年 | 36篇 |
1997年 | 22篇 |
1996年 | 20篇 |
1995年 | 21篇 |
1994年 | 16篇 |
1993年 | 10篇 |
1992年 | 11篇 |
1991年 | 8篇 |
1990年 | 6篇 |
1989年 | 4篇 |
1988年 | 6篇 |
1987年 | 3篇 |
1986年 | 4篇 |
1985年 | 7篇 |
1983年 | 6篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1976年 | 2篇 |
1975年 | 3篇 |
1974年 | 2篇 |
1972年 | 2篇 |
1968年 | 2篇 |
1948年 | 13篇 |
排序方式: 共有915条查询结果,搜索用时 15 毫秒
1.
Franois Ancien Fabrizio Pucci Marianne Rooman 《International journal of molecular sciences》2021,22(9)
Sphingomyelin phosphodiesterase (SMPD1) is a key enzyme in the sphingolipid metabolism. Genetic SMPD1 variants have been related to the Niemann-Pick lysosomal storage disorder, which has different degrees of phenotypic severity ranging from severe symptomatology involving the central nervous system (type A) to milder ones (type B). They have also been linked to neurodegenerative disorders such as Parkinson and Alzheimer. In this paper, we leveraged structural, evolutionary and stability information on SMPD1 to predict and analyze the impact of variants at the molecular level. We developed the SMPD1-ZooM algorithm, which is able to predict with good accuracy whether variants cause Niemann-Pick disease and its phenotypic severity; the predictor is freely available for download. We performed a large-scale analysis of all possible SMPD1 variants, which led us to identify protein regions that are either robust or fragile with respect to amino acid variations, and show the importance of aromatic-involving interactions in SMPD1 function and stability. Our study also revealed a good correlation between SMPD1-ZooM scores and in vitro loss of SMPD1 activity. The understanding of the molecular effects of SMPD1 variants is of crucial importance to improve genetic screening of SMPD1-related disorders and to develop personalized treatments that restore SMPD1 functionality. 相似文献
2.
Luc Rochette Loubna Mazini Gabriel Malka Marianne Zeller Yves Cottin Catherine Vergely 《International journal of molecular sciences》2020,21(23)
The potential use of stem cell-based therapies for the repair and regeneration of various tissues and organs is a major goal in repair medicine. Stem cells are classified by their potential to differentiate into functional cells. Compared with other sources, adipose-derived stem cells (ADSCs) have the advantage of being abundant and easy to obtain. ADSCs are considered to be tools for replacing, repairing, and regenerating dead or damaged cells. The capacity of ADSCs to maintain their properties depends on the balance of complex signals in their microenvironment. Their properties and the associated outcomes are in part regulated by reactive oxygen species, which mediate the oxidation-reduction state of cells as a secondary messenger. ADSC therapy has demonstrated beneficial effects, suggesting that secreted factors may provide protection. There is evidence that ADSCs secrete a number of cytokines, growth factors, and antioxidant factors into their microenvironment, thus regulating intracellular signaling pathways in neighboring cells. In this review, we introduce the roles of ADSCs in the protection of cells by modulating inflammation and immunity, and we develop their potential therapeutic properties. 相似文献
3.
4.
S Giralt E Estey M Albitar K van Besien G Rondón P Anderlini S O'Brien I Khouri J Gajewski R Mehra D Claxton B Andersson M Beran D Przepiorka C Koller S Kornblau M K?rbling M Keating H Kantarjian R Champlin 《Canadian Metallurgical Quarterly》1997,89(12):4531-4536
The immune-mediated graft-versus-leukemia effect is important to prevent relapse after allogeneic progenitor cell transplantation. This process requires engraftment of donor immuno-competent cells. The objective of this study was to assess the feasibility of achieving engraftment of allogeneic peripheral blood or bone marrow progenitor cell after purine analog containing nonmyeloablative chemotherapy. Patients with advanced leukemia or myelodysplastic syndromes (MDS) who were not candidates for a conventional myeloablative therapy because of older age or organ dysfunction were eligible. All patients had an HLA-identical or one-antigen-mismatched related donor. Fifteen patients were treated (13 with acute myeloid leukemia and 2 with MDS). The median age was 59 years (range, 27 to 71 years). Twelve patients were either refractory to therapy or beyond first relapse. Eight patients received fludarabine at 30 mg/m2/d for 4 days with idarubicin at 12 mg/m2/d for 3 days and ara-c at 2 g/m2/d for 4 days (n = 7) or melphalan at 140 mg/m2/d (n = 1). Seven patients received 2-chloro-deoxyadenosine at 12 mg/m2/d for 5 days and ara-C 1 at g/m2/d for 5 days. Thirteen patients received allogeneic peripheral blood stem cells and 1 received bone marrow after chemotherapy. Graft-versus-host disease (GVHD) prophylaxis consisted of cyclosporine and methyl-prednisolone. Treatment was generally well tolerated, with only 1 death from multiorgan failure before receiving stem cells. Thirteen patients achieved a neutrophil count of greater than 0.5 x 10(9)/L a median of 10 days postinfusion (range, 8 to 17 days). Ten patients achieved platelet counts of 20 x 10(9)/L a median of 13 days after progenitor cell infusion (range, 7 to 78 days). Eight patients achieved complete remissions (bone marrow blasts were < 5% with neutrophil recovery and platelet transfusion independence) that lasted a median of 60 days posttransplantation (range, 34 to 170+ days). Acute GVHD grade > or = 2 occurred in 3 patients. Chimerism analysis of bone marrow cells in 6 of 8 patients achieving remission showed > or = 90% donor cells between 14 and 30 days postinfusion, and 3 of 4 patients remaining in remission between 60 and 90 days continued to have > or = 80% donor cells. We conclude that purine analog-containing nonmyeloablative regimens allow engraftment of HLA-compatible hematopoietic progenitor cells. This approach permits us to explore the graft-versus-leukemia effect without the toxicity of myeloablative therapy and warrants further study in patients with leukemia who are ineligible for conventional transplantation with myeloablative regimens either because of age or concurrent medical conditions. 相似文献
5.
SM Kornblau E Estey T Madden HT Tran S Zhao U Consoli V Snell G Sanchez-Williams H Kantarjian M Keating RA Newman M Andreeff 《Canadian Metallurgical Quarterly》1997,15(5):1796-1802
PURPOSE: Expression of the multidrug resistance gene (MDR1) p170 protein is frequent in leukemic blasts from patients with relapsed acute myelogenous leukemia (AML). A phase I study using the nonimmunosuppressive MDR1 blocker SDZ PSC-833 (PSC) in combination with mitoxantrone (MITO) and etoposide (VP) was performed. PATIENTS AND METHODS: Starting doses (LVL0) of MITO (3.25 mg/m2/d on days 1 and 3 to 6) and VP (210 mg/m2/d on days 1 and 3 to 5) were 40% of the maximal-tolerated dose (MTD) from a prior study. A 1.5-mg/kg loading dose of PSC was followed by a 120-hour continuous infusion of 10 mg/kg/d on days 2 to 6. Blood samples for PSC, MITO, and VP pharmacokinetics (PK) were taken on days 1 and 3, and samples for MDR1 expression were taken on day 0. RESULTS: Severe mucositis developed in all patients at LVL0; therefore, MITO and VP doses were reduced to 2.5 and 170 mg/m2 (LVL-1) for the next seven patients, and this dose proved to be MTD. All LVL0 and three LVL-1 patients had transient elevations in the serum bilirubin level to > or = 4 mg/dL. Serum creatinine level increased to greater than 2 mg/dL in one case. There were no other grade 3 or 4 nonhematologic toxicities observed. The peripheral blood was cleared of leukemia in three LVL0 and four LVL-1 patients. The marrow was cleared of leukemic cells in one LVL0 and five LVL-1 patients, and a significant reduction in marrow leukemic infiltrate was observed in eight of 10. No patient achieved complete remission (CR), and all died of progressive disease (n = 8) or infection (n = 2). MDR1 expression was detected by fluorescent-activated cell sorter (FACS) analysis in five of seven cases. An elevated MDR1 mRNA level was detected by quantitative polymerase chain reaction (Q-PCR) in six of eight cases studied. Clearing of leukemia cells from the marrow occurred in four of six MDR1-positive and one of three MDR1-negative patients. Despite the fact that LVL0 doses had to be reduced due to toxicity, coadministration of PSC did not produce a consistent effect on MITO PK; however, it did repeatedly lead to increased levels of VP in the serum. CONCLUSION: We conclude that PSC-MITO-VP is a tolerable regimen with antileukemic activity. Addition of PSC necessitated a 66% reduction in MITO and VP doses from a prior study without PSC. 相似文献
6.
7.
8.
Peroxide crosslinking of unplasticized poly(vinyl chloride) with trimethylolpropane trimethacrylate was investigated. Formulations used in this work contained a nontoxic lead‐free stabilizer and showed good color and heat stability. The samples were examined by differential scanning calorimetry, and their tensile properties were measured at room temperature and at 130°C. Gel content or tetrahydrofuran‐insoluble material was measured as an indication of crosslinking. It was shown that premature crosslinking could be avoided during processing and that 190°C was the optimum processing temperature for maximum gel content. The residual unsaturation was monitored by using FTIR spectroscopy. J. VINYL ADDIT. TECHNOL., 2008. © 2008 Society of Plastics Engineers 相似文献
9.
AN Salt MM Henson SL Gewalt AW Keating JE DeMott OW Henson 《Canadian Metallurgical Quarterly》1995,88(1-2):79-86
The experiments carried out on the model of immobilization stress permit establishing the antiulcer effect of preventive introduction of sodium succinate solution, milk serum solution and solution of milk serum with sodium succinate. A decrease in the degree and number of ulcers and in the integrative indices characterizing the ulcer process after introduction of the studied drugs was accompanied by a fall of the intensity of lipid peroxidation processes. 相似文献
10.
Marie L. Borum Kathleen L. Shehan Hans Fromm Saleem Jahangeer Marianne K. Floor Oliver Alabaster 《Lipids》1992,27(12):999-1004
The effect and possible interactive influence of different dietary amounts of wheat bran, fat and calcium on the fecal excretion,
concentration and composition of bile acids was studied in Fischer-344 rats. The fecal bile acids were analyzed using gas-liquid
chromatography. Dietary wheat bran increased both total bile acid excretion and fecal weight without changes in fecal bile
acid concentration. The proportion of fecal hyodeoxycholic acid decreased with increasing dietary fiber, whereas that of lithocholic
and deoxycholic acids increased significantly with fiber intake. The percent content of fecal chenodeoxycholic acid did not
change. Increasing dietary fat led to an increase in bile acid excretion without changes in either fecal weight or bile acid
concentration. In contrast, the level of dietary calcium did not affect the total excretion of bile acids. However, since
calcium increased the fecal weight, it consequently diluted bile acids and decreased their fecal concentration. Dietary fat
and calcium had no influence on fecal bile acid composition. There were no interactive effects of wheat bran, fat and calcium
on fecal bile acids. The finding in this study that dietary fiber, fat and calcium induce significant changes in fecal bile
acids may be of relevance to the potential of bile acids to promote carcinogenesis. 相似文献